Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan and Zhi Yang
Journal of Nuclear Medicine February 2020, jnumed.119.235333; DOI: https://doi.org/10.2967/jnumed.119.235333
Chen Liu
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teli Liu
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhongyi Zhang
2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ning Zhang
3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Du
3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Yang
3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiqiang Liu
4 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Yu
5 Department of Urology, Peking University First Hospital, Beijing, 100034, China, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nan Li
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A Gorin
6 The James Buchanan Brady Urological Institute and Department of Urology, and The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, US., United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Rowe
6 The James Buchanan Brady Urological Institute and Department of Urology, and The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, US., United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Zhu
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun Yan
2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang Professor
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.235333
DOI 
https://doi.org/10.2967/jnumed.119.235333
PubMed 
32034111

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 7, 2020.

Article Versions

  • You are currently viewing a previous version of this article (February 7, 2020 - 14:31).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Chen Liu1,
  2. Teli Liu1,
  3. Zhongyi Zhang2,
  4. Ning Zhang3,
  5. Peng Du3,
  6. Yong Yang3,
  7. Yiqiang Liu4,
  8. Wei Yu5,
  9. Nan Li1,
  10. Michael A Gorin6,
  11. Steven P. Rowe6,
  12. Hua Zhu1,
  13. Kun Yan2 and
  14. Zhi Yang Professor1
  1. 1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  2. 2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  3. 3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  4. 4 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;
  5. 5 Department of Urology, Peking University First Hospital, Beijing, 100034, China, China;
  6. 6 The James Buchanan Brady Urological Institute and Department of Urology, and The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, US., United States
  1. For correspondence or reprints contact: Zhi Yang, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China, 52 Fucheng Rd, Beijing 100142, China. E-mail: pekyz@163.com

Statistics from Altmetric.com

Cited By...

  • 29 Citations
  • 28 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers
    Zhuoran Gong, Zhifei Dai
    Advanced Science 2021 8 10
  • Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis
    Swayamjeet Satapathy, Harmandeep Singh, Rajender Kumar, Bhagwant Rai Mittal
    American Journal of Roentgenology 2021 216 3
  • Prostate-specific Membrane Antigen PET in Prostate Cancer
    Courtney Lawhn-Heath, Ali Salavati, Spencer C. Behr, Steven P. Rowe, Jeremie Calais, Wolfgang P. Fendler, Mattias Eiber, Louise Emmett, Michael S. Hofman, Thomas A. Hope
    Radiology 2021 299 2
  • Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
    Daniela A. Ferraro, Anton S. Becker, Benedikt Kranzbühler, Iliana Mebert, Anka Baltensperger, Konstantinos G. Zeimpekis, Hannes Grünig, Michael Messerli, Niels J. Rupp, Jan H. Rueschoff, Ashkan Mortezavi, Olivio F. Donati, Marcelo T. Sapienza, Daniel Eberli, Irene A. Burger
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 10
  • Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
    Dejan Kostyszyn, Tobias Fechter, Nico Bartl, Anca L. Grosu, Christian Gratzke, August Sigle, Michael Mix, Juri Ruf, Thomas F. Fassbender, Selina Kiefer, Alisa S. Bettermann, Nils H. Nicolay, Simon Spohn, Maria U. Kramer, Peter Bronsert, Hongqian Guo, Xuefeng Qiu, Feng Wang, Christoph Henkenberens, Rudolf A. Werner, Dimos Baltas, Philipp T. Meyer, Thorsten Derlin, Mengxia Chen, Constantinos Zamboglou
    Journal of Nuclear Medicine 2021 62 6
  • Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China
    Zeyu Zhang, Kunshan He, Chongwei Chi, Zhenhua Hu, Jie Tian
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 8
  • 64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
    Teli Liu, Chen Liu, Zhongyi Zhang, Ning Zhang, Xiaoyi Guo, Lei Xia, Jinquan Jiang, Qing Xie, Kun Yan, Steven P. Rowe, Hua Zhu, Zhi Yang
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 13
  • Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
    Tatsushi Kawada, Takafumi Yanagisawa, Pawel Rajwa, Reza Sari Motlagh, Hadi Mostafaei, Fahad Quhal, Ekaterina Laukhtina, Abdulmajeed Aydh, Frederik König, Maximilian Pallauf, Benjamin Pradere, Francesco Ceci, Pascal A.T. Baltzer, Marcus Hacker, Sazan Rasul, Pierre I. Karakiewicz, Motoo Araki, Yasutomo Nasu, Shahrokh F. Shariat
    European Urology Oncology 2022 5 4
  • Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study
    Dong-Xu Qiu, Jian Li, Jin-Wei Zhang, Min-Feng Chen, Xiao-Mei Gao, Yong-Xiang Tang, Ye Zhang, Xiao-Ping Yi, Hong-ling Yin, Yu Gan, Gui-Lin Wang, Xiong-Bing Zu, Shuo Hu, Yi Cai
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 8
  • The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
    Anna Rebecca Lisney, Conrad Leitsmann, Arne Strauß, Birgit Meller, Jan Alexander Bucerius, Carsten-Oliver Sahlmann
    Cancers 2022 14 15

Article usage

Article usage: February 2020 to January 2023

AbstractFullPdf
Feb 2020521047
Mar 2020236014
Apr 2020131013
May 2020104012
Jun 20208307
Jul 20205805
Aug 202098047
Sep 2020138418110
Oct 2020247534
Nov 2020182921
Dec 2020119621
Jan 2021106721
Feb 202113999
Mar 2021545326
Apr 2021463513
May 2021344029
Jun 2021413637
Jul 2021293036
Aug 2021292821
Sep 2021235131
Oct 2021263565
Nov 2021192731
Dec 2021363826
Jan 2022324031
Feb 2022272019
Mar 2022243323
Apr 2022355434
May 2022173333
Jun 2022162729
Jul 2022133038
Aug 2022107025
Sep 2022187922
Oct 2022222328
Nov 2022213221
Dec 2022132217
Jan 2023172723
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (2)
Journal of Nuclear Medicine
Vol. 64, Issue 2
February 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies
Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, Zhi Yang
Journal of Nuclear Medicine Feb 2020, jnumed.119.235333; DOI: 10.2967/jnumed.119.235333

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies
Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, Zhi Yang
Journal of Nuclear Medicine Feb 2020, jnumed.119.235333; DOI: 10.2967/jnumed.119.235333
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
  • An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients
  • Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
  • An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients
  • Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Oncology: GU
  • PET
  • PET/CT
  • PSMA
  • biopsy
  • prostate cancer
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire